Influenza infection contributes substantially to global morbidity and mortality, with children
undergoing treatment for cancer among the most vulnerable due to immunosuppression …

Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …

Risk factors for severity in seasonal respiratory viral infe... : Current Opinion in Infectious
Diseases Risk factors for severity in seasonal respiratory viral infections and how they guide …

Background There is considerable variation in vaccination practices between pediatric
transplant centers. This study aims to evaluate active immunization attitudes and practices …

Objectives: The current study aims to survey the willingness of parents to vaccinate their
children, who are childhood acute lymphoblastic leukemia survivors (CALLS), and identify …

Background Our previous study established a 2-dose regimen of high-dose trivalent
influenza vaccine (HD-TIV) to be immunogenically superior compared to a 2-dose regimen …

Viral infections are a major cause of morbidity and mortality in pediatric transplant patients.
Antiviral drugs are used to prevent and treat these infections, but therapeutic options are …

Pediatric hematopoietic cell transplant (HCT) recipients exhibit poor serologic responses to
influenza vaccination early after transplant. To facilitate the optimization of influenza …

Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses
(CARVs) were a significant threat to the health and well‐being of allogeneic hematopoietic …

To the Editor: There has been a rapid global response in vaccine development since
declaration of the COVID-19 pandemic in March 2020. Data are beginning to emerge …